Descrease article font size Increase article font size Health Canada on Thursday approved another respiratory syncytial virus (RSV) vaccine for adults over the age of 60 and pregnant people. Pfizer’s bivalent RSV vaccine, Abrysvo, has been authorized for the use of pregnant individuals from 32 through 36 weeks gestational age for the prevention of lower respiratory … Read more
A winter virus jab for babies could ease the burden on the NHS, scientists have said, after a large clinical trial has shown it can reduce related hospital admissions by more than 80%. Results from the Harmonie study suggest a single shot of nirsevimab offers immediate protection against RSV (Respiratory Syncytial Virus) – a common … Read more
As Canadians continue to enjoy the last bit of summer’s sun-soaked days, doctors say they are bracing for a potential “tripledemic” of influenza, respiratory syncytial virus (RSV) and COVID-19, signalling the imminent arrival of respiratory flu season. Last flu season — which typically runs from November to March in Canada — saw a surge of … Read more